Skip to main content
Top
Published in: Clinical Rheumatology 2/2021

01-02-2021 | Spondyloarthropathy | Original Article

The journey of the non-radiographic axial spondyloarthritis patient: the perspective of professionals and patients

Authors: Teresa Otón, Carlos Sastre, Loreto Carmona

Published in: Clinical Rheumatology | Issue 2/2021

Login to get access

Abstract

Objective

Explore the perspective of patients and professionals regarding non-radiographic axial spondyloarthritis (nr-axSpA) and to define the patient’s journey from diagnosis to treatment in order to identify unmet needs during the process.

Methods

A qualitative study was carried out in two phases. In the first part, five focus groups were held with rheumatologists, orthopaedist, physiotherapists, primary care physicians (PCP), radiologists and six narrative interviews with nr-axSpA patients. In the second part, a nominal group meeting was held to detect which needs were not covered in the nr-axSpA (all of whom had collaborated in the previous phase).

Results

The topics discussed with professional groups and patients were the appropriateness of the term and concept of nr-axSpA, the management of low back pain and inflammatory back pain in routine clinical practice, complementary test and the problem of waiting lists and finally the unmet needs both from a practitioner’s and a patient’s perspective. The final group explored solutions to the problems based on what was discussed in the first part of the project. Some of these solutions were strengthening relations between specialties, implementing high resolution consultations, rethinking the disability scales, offering better information to patients, designing resource maps and using different strategies to promote knowledge of the disease.

Conclusion

Many different perspectives on the same disease have revealed the difficult journey of the patient with suspected nr-axSpA, while identifying problems and solutions.
Key Points
• Diagnosis of nr-AxSpA among health professionals outside rheumatology may lead to numerous turns and difficulties in the patient’s journey.
• The impact of delays and complications in the journey to diagnosis is not quantified but directly affects the state of well-being and health of patients.
• Multidisciplinary care is far from a reality. Primary care (key specialists in any chronic condition), radiologists, orthopaedists, and non-physicians such as physiotherapists and psychologists are generally excluded from dealing with these patients, and often have to do their work outside of physicians, rather than working together in a truly patient-centred medicine.
Literature
1.
go back to reference Braun J, Baraliakos X, Kiltz U (2016) Non-radiographic axial spondyloarthritis: a classification or a diagnosis? Clin Exp Rheumatol 34(1 Suppl 95):S5–S6PubMed Braun J, Baraliakos X, Kiltz U (2016) Non-radiographic axial spondyloarthritis: a classification or a diagnosis? Clin Exp Rheumatol 34(1 Suppl 95):S5–S6PubMed
2.
go back to reference Fianyo E, Wendling D, Poulain C, Farrenq V, Claudepierre P (2014) Non-radiographic axial spondyloarthritis: what is it? Clin Exp Rheumatol 32(1):1–4PubMed Fianyo E, Wendling D, Poulain C, Farrenq V, Claudepierre P (2014) Non-radiographic axial spondyloarthritis: what is it? Clin Exp Rheumatol 32(1):1–4PubMed
7.
go back to reference van der Heijde D, Ramiro S, Landewe R, Baraliakos X, Van den Bosch F, Sepriano A, Regel A, Ciurea A, Dagfinrud H, Dougados M, van Gaalen F, Geher P, van der Horst-Bruinsma I, Inman RD, Jongkees M, Kiltz U, Kvien TK, Machado PM, Marzo-Ortega H, Molto A, Navarro-Compan V, Ozgocmen S, Pimentel-Santos FM, Reveille J, Rudwaleit M, Sieper J, Sampaio-Barros P, Wiek D, Braun J (2017) 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 76(6):978–991. https://doi.org/10.1136/annrheumdis-2016-210770CrossRefPubMed van der Heijde D, Ramiro S, Landewe R, Baraliakos X, Van den Bosch F, Sepriano A, Regel A, Ciurea A, Dagfinrud H, Dougados M, van Gaalen F, Geher P, van der Horst-Bruinsma I, Inman RD, Jongkees M, Kiltz U, Kvien TK, Machado PM, Marzo-Ortega H, Molto A, Navarro-Compan V, Ozgocmen S, Pimentel-Santos FM, Reveille J, Rudwaleit M, Sieper J, Sampaio-Barros P, Wiek D, Braun J (2017) 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 76(6):978–991. https://​doi.​org/​10.​1136/​annrheumdis-2016-210770CrossRefPubMed
8.
go back to reference Ward MM, Deodhar A, Akl EA, Lui A, Ermann J, Gensler LS, Smith JA, Borenstein D, Hiratzka J, Weiss PF, Inman RD, Majithia V, Haroon N, Maksymowych WP, Joyce J, Clark BM, Colbert RA, Figgie MP, Hallegua DS, Prete PE, Rosenbaum JT, Stebulis JA, van den Bosch F, Yu DT, Miller AS, Reveille JD, Caplan L (2016) American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and treatment network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheum 68(2):282–298. https://doi.org/10.1002/art.39298CrossRef Ward MM, Deodhar A, Akl EA, Lui A, Ermann J, Gensler LS, Smith JA, Borenstein D, Hiratzka J, Weiss PF, Inman RD, Majithia V, Haroon N, Maksymowych WP, Joyce J, Clark BM, Colbert RA, Figgie MP, Hallegua DS, Prete PE, Rosenbaum JT, Stebulis JA, van den Bosch F, Yu DT, Miller AS, Reveille JD, Caplan L (2016) American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and treatment network 2015 recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis. Arthritis Rheum 68(2):282–298. https://​doi.​org/​10.​1002/​art.​39298CrossRef
17.
go back to reference Ciurea A, Scherer A, Exer P, Bernhard J, Dudler J, Beyeler B, Kissling R, Stekhoven D, Rufibach K, Tamborrini G, Weiss B, Muller R, Nissen MJ, Michel BA, van der Heijde D, Dougados M, Boonen A, Weber U, Rheumatologists of the Swiss Clinical Quality Management Program for Axial S (2013) Tumor necrosis factor alpha inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort. Arthritis Rheum 65(12):3096–3106. https://doi.org/10.1002/art.38140CrossRefPubMed Ciurea A, Scherer A, Exer P, Bernhard J, Dudler J, Beyeler B, Kissling R, Stekhoven D, Rufibach K, Tamborrini G, Weiss B, Muller R, Nissen MJ, Michel BA, van der Heijde D, Dougados M, Boonen A, Weber U, Rheumatologists of the Swiss Clinical Quality Management Program for Axial S (2013) Tumor necrosis factor alpha inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort. Arthritis Rheum 65(12):3096–3106. https://​doi.​org/​10.​1002/​art.​38140CrossRefPubMed
18.
go back to reference Kiltz U, Baraliakos X, Karakostas P, Igelmann M, Kalthoff L, Klink C, Krause D, Schmitz-Bortz E, Florecke M, Bollow M, Braun J (2012) The degree of spinal inflammation is similar in patients with axial spondyloarthritis who report high or low levels of disease activity: a cohort study. Ann Rheum Dis 71(7):1207–1211. https://doi.org/10.1136/annrheumdis-2011-200508CrossRefPubMed Kiltz U, Baraliakos X, Karakostas P, Igelmann M, Kalthoff L, Klink C, Krause D, Schmitz-Bortz E, Florecke M, Bollow M, Braun J (2012) The degree of spinal inflammation is similar in patients with axial spondyloarthritis who report high or low levels of disease activity: a cohort study. Ann Rheum Dis 71(7):1207–1211. https://​doi.​org/​10.​1136/​annrheumdis-2011-200508CrossRefPubMed
21.
go back to reference Wallman JK, Joud A, Olofsson T, Jacobsson LTH, Bliddal H, Kristensen LE (2017) Work disability in non-radiographic axial spondyloarthritis patients before and after start of anti-TNF therapy: a population-based regional cohort study from southern Sweden. Rheumatology (Oxford) 56(5):716–724. https://doi.org/10.1093/rheumatology/kew473CrossRef Wallman JK, Joud A, Olofsson T, Jacobsson LTH, Bliddal H, Kristensen LE (2017) Work disability in non-radiographic axial spondyloarthritis patients before and after start of anti-TNF therapy: a population-based regional cohort study from southern Sweden. Rheumatology (Oxford) 56(5):716–724. https://​doi.​org/​10.​1093/​rheumatology/​kew473CrossRef
24.
go back to reference Kjeken I, Dagfinrud H, Mowinckel P, Uhlig T, Kvien TK, Finset A (2006) Rheumatology care: involvement in medical decisions, received information, satisfaction with care, and unmet health care needs in patients with rheumatoid arthritis and ankylosing spondylitis. Arthritis Rheum 55(3):394–401. https://doi.org/10.1002/art.21985CrossRefPubMed Kjeken I, Dagfinrud H, Mowinckel P, Uhlig T, Kvien TK, Finset A (2006) Rheumatology care: involvement in medical decisions, received information, satisfaction with care, and unmet health care needs in patients with rheumatoid arthritis and ankylosing spondylitis. Arthritis Rheum 55(3):394–401. https://​doi.​org/​10.​1002/​art.​21985CrossRefPubMed
Metadata
Title
The journey of the non-radiographic axial spondyloarthritis patient: the perspective of professionals and patients
Authors
Teresa Otón
Carlos Sastre
Loreto Carmona
Publication date
01-02-2021
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 2/2021
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05269-z

Other articles of this Issue 2/2021

Clinical Rheumatology 2/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.